Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

24.57
+6.0532.67%
Post-market: 24.580.0100+0.04%19:57 EST
Volume:12.70M
Turnover:311.29M
Market Cap:1.67B
PE:-8.07
High:26.21
Open:22.75
Low:22.00
Close:18.52
52wk High:35.12
52wk Low:9.98
Shares:67.80M
Float Shares:61.84M
Volume Ratio:9.81
T/O Rate:20.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0460
EPS(LYR):-1.4671
ROE:-97.88%
ROA:-6.23%
PB:10.74
PE(LYR):-16.75

Loading ...

UBS Adjusts Price Target on Tandem Diabetes Care to $22 From $17, Maintains Neutral Rating

MT Newswires Live
·
Feb 20

Stock Track | Tandem Diabetes Care Soars 22.83% Intraday on Strong Q4 Earnings Beat and BofA Upgrade

Stock Track
·
Feb 20

Tandem Diabetes Care Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Feb 20

RBC Capital Remains a Buy on Tandem Diabetes Care (TNDM)

TIPRANKS
·
Feb 20

Stock Track | Tandem Diabetes Care Soars 9.29% in Pre-Market on BofA Upgrade and Strong Q4 Earnings Beat

Stock Track
·
Feb 20

Tandem Diabetes upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Feb 20

Tandem Diabetes Care Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 20

Stock Track | Tandem Diabetes Care Soars 6.70% on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track
·
Feb 20

Earnings Flash (TNDM) Tandem Diabetes Care Posts Q4 Loss $0.01, vs. FactSet Est of $0.07 Loss

MT Newswires Live
·
Feb 20

Stock Track | Tandem Diabetes Care Soars 15.01% After-Hours on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track
·
Feb 20

Tandem Diabetes Q4 sales rise

Reuters
·
Feb 20

BRIEF-Tandem Diabetes Care Q4 Adjusted Operating Income USD 8.3 Million Vs. IBES Estimate USD -4.79 Million

Reuters
·
Feb 20

Tandem Diabetes Care Q4 Net Income USD -600 Thousand

THOMSON REUTERS
·
Feb 20

Tandem Diabetes Care Sales for the FY 2026 Estimated to Be About $1.065 Billion to $1.085 Billion

THOMSON REUTERS
·
Feb 20

Tandem Diabetes Care Outlook FY Adjusted Ebitda Margin 5-6%

THOMSON REUTERS
·
Feb 20

Tandem Diabetes Care Inc: Sales for Full Year Are Estimated to Be Approximately $1.065 Bln to $1.085 Bln

THOMSON REUTERS
·
Feb 20

Tandem Diabetes Care Q4 Gross Margin 58%

THOMSON REUTERS
·
Feb 20

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance

THOMSON REUTERS
·
Feb 20

Tandem Diabetes Care to Present Company Update at Major Investor Conferences

Reuters
·
Feb 13

Tandem Diabetes Care Announces Upcoming Conference Presentations

THOMSON REUTERS
·
Feb 13